Adjuvant Chemotherapy for Resected Non‐Small Cell Carcinoma of the Lung: Why We Still Don't Know

Oncologist - United States
doi 10.1634/theoncologist.3-1-35
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Alphamed Press

Related search

Oncologic Treatment of Non-Small Cell Lung Cancer Part B: Adjuvant Chemotherapy for Resected Non-Small Cell Lung Carcinoma

2013English

P2.16-36 Adjuvant Chemotherapy Is Effective for Completely Resected Stage IB Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Adjuvant Therapy for Resected Non–Small-Cell Lung Cancer With Lymphovascular Invasion

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2013English

P1.09-07 PD-L1 Protein Expression Is a Predictor of Benefit From Adjuvant Chemotherapy in Resected Non-Small Cell Lung Carcinoma

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Multidrug Resistance Proteins Do Not Predict Benefit of Adjuvant Chemotherapy in Patients With Completely Resected Non-Small Cell Lung Cancer: International Adjuvant Lung Cancer Trial Biologic Program

Clinical Cancer Research
Cancer ResearchOncology
2007English

Clinical Response to Chemotherapy in Non-Small Cell Lung Carcinoma Patients

International Journal of Research in Medical Sciences
2019English

Is DNA Ploidy Pattern a Prognostic Factor for Postoperative Adjuvant Chemotherapy for Non-Small Cell Lung Cancer?

Japanese Journal of Lung Cancer
OncologyRespiratory MedicinePulmonary
2001English

Palliative Chemotherapy for Advanced Non-Small Cell Lung Cancer

BMJ
1994English

P2.16-45 Should Patients With Stage IB Non-Small Cell Lung Cancer Receive Adjuvant Chemotherapy?

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy